Application of current knowledge to the management of bleeding events during immune tolerance induction

Jorge Di Paola(Washington University in St. Louis), Cindy Leissinger(National Institutes of Health), Louis M. Aledort(Icahn School of Medicine at Mount Sinai), Manuel Carção(Hospital for Sick Children), Christine L. Kempton(Emory University), Eríc F. Grabowski(Harvard University), Janna M. Journeycake(University of Oklahoma Health Sciences Center), Julia Hütter(National Institutes of Health), Howard A. Britton(The University of Texas at San Antonio Health Science Center)
Haemophilia
October 18, 2006
10.1111/j.1365-2516.2006.01343.x
Cited by 5

Related Papers

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
|PubMed|2001|803
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613
A More Uniform Measurement of Factor VIII Inhibitors
|Thrombosis and Haemostasis|1975|587